Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 2/20 | 0.63 |
| ▸ | JAK2 | O60674 | 3/20 | 0.50 |
| ▸ | BRD4 | O60885 | 3/20 | 0.50 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.49 |
| ▸ | KDR | P35968 | 1/20 | 0.49 |
| ▸ | PAK1 | Q13153 | 8/20 | 0.48 |
| ▸ | TNK2 | Q07912 | 1/20 | 0.47 |
| ▸ | JAK3 | P52333 | 3/20 | 0.47 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.46 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16514436 | 0.92 | EGFR (0.62) | EGFRJAK2BRD4FGFR1KDR | |
| SCHEMBL16513747 | 0.90 | EGFR (0.61) | EGFRJAK2BRD4FGFR1KDR | |
| SCHEMBL16514550 | 0.90 | EGFR (0.61) | EGFRJAK2BRD4FGFR1KDR | |
| SCHEMBL18527556 | 0.89 | EGFR (0.51) | EGFRJAK2BRD4FGFR1KDR | |
| SCHEMBL16514587 | 0.85 | FGFR1 (0.55) | EGFRJAK2BRD4FGFR1KDR | |
| Fumaric Acid SCHEMBL16514259 | 0.83 | FGFR1 (0.56) | EGFRJAK2BRD4FGFR1KDR | |
| Maleic Acid SCHEMBL16514328 | 0.83 | FGFR1 (0.56) | EGFRJAK2BRD4FGFR1KDR | |
| SCHEMBL16513550 | 0.82 | BRD4 (0.53) | EGFRJAK2BRD4FGFR1KDR | |
| SCHEMBL16514170 | 0.82 | EGFR (0.82) | EGFRJAK2BRD4FGFR1KDR | |
| SCHEMBL29848400 | 0.82 | EGFR (0.82) | EGFRJAK2BRD4FGFR1KDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3035936-A2 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | NeuPharma, Inc. (US) | 2016-06-29 | — | — | EP | disclosed |
| WO-2015027222-A2 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS | NEUPHARMA, INC. (US) | 2015-02-26 | — | — | WO | disclosed |